Why CBD Makes Me Tired: How It Affects Sleep and Energy - Mustaf Medical
Understanding Why CBD Makes Me Tired
Introduction
Emily, a marketing professional in her early thirties, often works late evenings and battles intermittent shoulder tension from hours at a computer. She began taking a daily cbd gummies product for humans after reading about its reputed calming effects. Over several weeks she noticed that on the evenings she took the gummies she felt unusually drowsy, sometimes nodding off before finishing her work. The experience raised a simple question: why does CBD sometimes make people feel tired? The answer lies in a combination of pharmacology, individual biology, and the context in which CBD is consumed. Below is an evidence‑based overview that brings together recent clinical data, mechanistic insights, and safety considerations without promoting any specific product.
Background
CBD (cannabidiol) is a non‑psychoactive phytocannabinoid extracted primarily from Cannabis sativa or hemp plants. Unlike THC, it does not produce a "high," but it interacts with the body's endocannabinoid system (ECS) and several other molecular pathways. Interest in CBD has grown dramatically since the 2018 U.S. Farm Bill legalized hemp‑derived products containing less than 0.3 % THC, leading to a surge in gummies, oils, vapes, and topical creams. Researchers have examined CBD for anxiety, chronic pain, epilepsy, and sleep disorders, yet the evidence remains heterogeneous. Fatigue is frequently reported as a side effect in clinical trials, but the underlying mechanisms are still being clarified.
Comparative Context
| Source/Form | Absorption / Metabolic Impact | Intake Ranges Studied | Limitations | Populations Studied |
|---|---|---|---|---|
| CBD Oil (sublingual) | Rapid uptake via oral mucosa; first‑pass liver metabolism reduces bioavailability to ~10‑20 % | 5‑30 mg/day | Variable dosing accuracy; taste issues | Adults with anxiety, chronic pain |
| CBD Gummies (edible) | Digestion slows absorption; peak plasma levels 2‑4 h; bioavailability 4‑12 % | 10‑25 mg per gummy, 1‑2 gummies/day | Sugar content; delayed onset may affect timing | General adult consumers, mild insomnia |
| CBD Vape (inhalation) | Pulmonary absorption is fast; bioavailability up to 31 % | 2‑10 mg/session | Respiratory irritation; dosing inconsistency | Heavy‑stress professionals, short‑term use |
| Hemp Seed (food) | Minimal CBD; mainly nutrients; negligible pharmacologic effect | <1 mg CBD per serving | Not a therapeutic source of CBD | Nutritional studies, general population |
Population trade‑offs
- Sublingual oil delivers quicker effects, which can be advantageous for acute anxiety but may amplify central nervous system (CNS) depression in sensitive individuals.
- Gummies provide a convenient, discreet format and a slower rise in plasma CBD, potentially aligning better with evening routines aimed at relaxation. However, the delayed peak can coincide with natural circadian dip, increasing perceived tiredness.
- Vaping yields the fastest onset and highest bioavailability, useful for rapid symptom control but carries respiratory risks and may produce a sharper, more noticeable sedation.
- Hemp seed contributes little CBD; its inclusion in a diet is primarily for omega‑3 fatty acids and protein, not for cannabinoid effects.
Science and Mechanism (≈530 words)
Pharmacokinetics and Metabolism
When CBD is ingested, it undergoes extensive first‑pass metabolism in the liver, primarily via cytochrome P450 enzymes CYP3A4 and CYP2C19. The resulting metabolites-such as 7‑hydroxy‑CBD-retain some activity but are generally less potent at cannabinoid receptors. Oral bioavailability varies widely (4‑20 %) depending on formulation, presence of lipids, and individual gastrointestinal factors. This variability contributes to inconsistent plasma concentrations across users, which in turn influences how likely CBD is to produce fatigue.
Interaction with the Endocannabinoid System
CBD has low affinity for CB1 and CB2 receptors but acts as a negative allosteric modulator of CB1. By subtly dampening CB1 signaling, CBD can reduce excitatory neurotransmission that normally promotes wakefulness. Additionally, CBD enhances signaling of the serotonin 5‑HT1A receptor, which can produce anxiolytic and sedative outcomes. In animal models, 5‑HT1A activation has been linked to reduced locomotor activity and increased REM sleep duration.
Adenosine Modulation
One of the more consistently reported mechanisms involves adenosine. CBD inhibits the reuptake of adenosine, raising extracellular levels. Adenosine is a sleep‑promoting neuromodulator; its accumulation in the basal forebrain and other brain regions encourages the transition from wakefulness to sleep. This pathway explains why some participants in clinical trials report a "relaxing" rather than a "sleepy" effect-CBD may simply augment the brain's natural homeostatic drive toward rest.
GABAergic and Calcium Channel Effects
CBD also potentiates GABA‑A receptor activity and blocks voltage‑gated calcium channels (e.g., Cav2.2). Enhanced GABAergic transmission leads to neuronal hyperpolarization, decreasing excitability. Calcium channel inhibition reduces neurotransmitter release, further dampening arousal circuits. These actions are modest compared with traditional sedatives, but when combined with individual sensitivity, they can tip the balance toward fatigue.
Dose‑Response Relationship
Most human studies assess doses between 5 mg and 150 mg per day. A 2023 double‑blind trial by GW Pharmaceuticals (n=84) evaluated 20 mg vs. 40 mg oral CBD in adults with chronic anxiety. The 40 mg group reported a statistically higher incidence of daytime drowsiness (22 %) versus the 20 mg group (9 %). Conversely, a 2022 pilot study of 10 mg CBD oil in healthy volunteers showed no significant change in alertness measured by the Psychomotor Vigilance Test. The emerging consensus suggests a threshold effect: doses below ~15 mg/day are unlikely to cause noticeable fatigue for most adults, while higher doses increase the probability, especially when taken in the evening.
Individual Variability
Genetic polymorphisms in CYP2C19 and CYP3A4 can accelerate or decelerate CBD clearance, leading to higher or lower systemic exposure. Body mass index (BMI), diet (high‑fat meals improve absorption), and concurrent use of other CNS depressants (e.g., benzodiazepines, alcohol) also modulate the sedative potential. For example, a 2024 pharmacogenetic analysis involving 212 participants demonstrated that carriers of the CYP2C19*2 loss‑of‑function allele exhibited 1.8‑fold higher CBD plasma levels after a 25 mg dose, correlating with increased self‑reported fatigue.
Chronobiology Considerations
CBD may interact with the body's circadian rhythm. A 2021 chronobiology study observed that evening administration of 25 mg CBD shifted melatonin onset by approximately 30 minutes earlier than placebo, suggesting a mild phase‑advancing effect. This shift can be beneficial for individuals with delayed sleep phase syndrome but may be perceived as unwanted tiredness if the timing does not align with personal schedules.
Summary of Mechanistic Evidence
- Moderate evidence: CBD's inhibition of adenosine reuptake and 5‑HT1A agonism reliably produce mild sedation in preclinical models and human trials.
- Strong evidence: Pharmacokinetic variability, especially at higher oral doses, explains the wide range of fatigue reports.
- Emerging evidence: Genetic factors and chronobiology may tailor individual responses, but larger studies are needed.
Safety
Overall, CBD is well‑tolerated, with an adverse‑event profile comparable to placebo in many trials. The most common side effects include dry mouth, light‑headedness, and fatigue or drowsiness. Specific populations that should exercise caution include:
- Pregnant or breastfeeding individuals: insufficient data to confirm safety.
- People taking anticoagulants (e.g., warfarin) or antiepileptic drugs: CBD can inhibit CYP enzymes, potentially altering drug levels.
- Individuals with hepatic impairment: reduced metabolism may elevate CBD concentrations, increasing sedation risk.
- Elderly patients: age‑related declines in hepatic function and polypharmacy raise the likelihood of interactions.
Healthcare professionals typically recommend starting with a low dose (e.g., 5 mg) and monitoring for drowsiness, especially when the product is taken later in the day. Adjusting the timing-shifting consumption to early evening or after dinner-can mitigate unwanted daytime fatigue while preserving any intended calming effect.
Frequently Asked Questions
1. Does CBD cause the same level of tiredness for everyone?
No. Fatigue responses vary widely due to differences in dose, formulation, metabolism, and concurrent medications. While some people feel a gentle calm, others experience noticeable drowsiness, particularly at higher oral doses taken close to bedtime.
2. Can I take CBD in the morning without feeling sleepy?
Lower doses (≤10 mg) taken on an empty stomach are less likely to induce sleepiness, but individual sensitivity matters. Starting with a small amount and assessing alertness after a few hours is advisable.
3. Are there any long‑term risks associated with daily CBD‑induced fatigue?
Current long‑term studies (up to 2 years) have not identified persistent adverse effects directly linked to fatigue. However, chronic daytime sleepiness could affect productivity or safety, so monitoring and dose adjustment are prudent.
4. How does a "cbd gummies product for humans" differ from oil regarding tiredness?
Gummies are digested, leading to a slower rise in blood CBD levels that often peaks during the evening, potentially overlapping with natural circadian dips. Oil taken sublingually reaches peak concentrations quicker, which may produce a shorter‑duration sedative effect.
5. Should I avoid CBD if I already take sleep medication?
Combining CBD with prescription sleep aids can amplify sedation. Consultation with a healthcare provider is recommended to evaluate possible additive effects and adjust dosages safely.
This content is for informational purposes only. Always consult a healthcare professional before starting any supplement.